Using T1 mapping indices to evaluate muscle function and predict conservative treatment outcomes in diabetic patients with peripheral arterial disease

[1] Ihnat DM(2010)Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes J Vasc Surg 52 92S-95S

[2] Mills JL(2015)Peripheral arterial disease and revascularization of the diabetic foot Diabetes Obes Metab 17 435-444

[3] Forsythe RO(2016)Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study J Cardiovasc Magn Reson 18 76-59

[4] Brownrigg J(2012)Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T(1) mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study Circ Cardiovasc Imaging 5 51-144

[5] Hinchliffe RJ(2017)Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease J Biomed Sci 24 42-1216

[6] Mygind ND(2016)Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease J Transl Med 14 39-3950

[7] Michelsen MM(2010)Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans Circulation 122 138-816

[8] Pena A(2012)Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality Circulation 126 1206-137

[9] Ng AC(2020)Peripheral arterial disease: the role of extracellular volume measurements in lower limb muscles with MRI Eur Radiol 30 3943-213

[10] Auger D(2018)2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European So

[1] Ihnat DM(2010)Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes J Vasc Surg 52 92S-95S

[2] Mills JL(2015)Peripheral arterial disease and revascularization of the diabetic foot Diabetes Obes Metab 17 435-444

[3] Forsythe RO(2016)Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study J Cardiovasc Magn Reson 18 76-59

[4] Brownrigg J(2012)Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T(1) mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study Circ Cardiovasc Imaging 5 51-144

[5] Hinchliffe RJ(2017)Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease J Biomed Sci 24 42-1216

[6] Mygind ND(2016)Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease J Transl Med 14 39-3950

[7] Michelsen MM(2010)Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans Circulation 122 138-816

[8] Pena A(2012)Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality Circulation 126 1206-137

[9] Ng AC(2020)Peripheral arterial disease: the role of extracellular volume measurements in lower limb muscles with MRI Eur Radiol 30 3943-213

[10] Auger D(2018)2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European So